LBMON177 Dosing And Titration Of Osilodrostat In A Real-world Cohort Of US Patients With Endogenous Cushing's Disease: Analysis Of The ILLUSTRATE Study
Ioachimescu, Adriana Gabriela, Joseph Auchus, Richard, Huang, Wenyu, Spencer-Segal, Joanna L, Ji Yuen, Kevin Choong, Dacus, Kelley C, Ludlam, William Henry, Babler, Elizabeth Kay, Das, Ashis K, Campos, Cynthia, Broder, Michael S, Fleseriu, Maria
Published in Journal of the Endocrine Society (01.11.2022)
Published in Journal of the Endocrine Society (01.11.2022)
Get full text
Journal Article
LBMON176 Management, Safety, And Efficacy Of Osilodrostat Treatment In US Patients With Non-pituitary Cushing's Syndrome: Results From The ILLUSTRATE Study
Auchus, Richard Joseph, Fleseriu, Maria, Huang, Wenyu, Spencer-Segal, Joanna L, Yuen, Kevin Choong Ji, Dacus, Kelley C, Ludlam, William Henry, Babler, Elizabeth Kay, Das, Ashis K, Campos, Cynthia, Broder, Michael S, Ioachimescu, Adriana Gabriela
Published in Journal of the Endocrine Society (01.11.2022)
Published in Journal of the Endocrine Society (01.11.2022)
Get full text
Journal Article
OR23-07 Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study of Oral Octreotide Capsules in Adult Patients with Acromegaly
Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article
MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study
Fleseriu, Maria, Samson, Susan Leanne, Nachtigall, Lisa B, Labadzhyan, Artak, Elenkova, Atanaska, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article
One-Year Outcomes of the Open-Label Extension of CHIASMA OPTIMAL, a Phase 3 Study of Oral Octreotide Capsules in Acromegaly
Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Molitch, Mark E, Giustina, Andrea, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Kennedy, Laurence, Sever, Mojca Jensterle, Manning, Patrick John, Elenkova, Atanaska, Melmed, Shlomo, Strasburger, Christian Joseph
Published in Journal of the Endocrine Society (03.05.2021)
Published in Journal of the Endocrine Society (03.05.2021)
Get full text
Journal Article
MON-LB57 Impact of Imputation Method and Response Cutoffs on Results From the Phase 3 OPTIMAL Study of Oral Octreotide Capsules in Adult Patients With Acromegaly
Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Jensterle, Mojca, Elenkova, Atanaska, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Trainer, Peter James, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article
MON-297 Withdrawal from Long-Acting Somatostatin Receptor Ligand Injections in Adult Patients with Acromegaly: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study
Nachtigall, Lisa B, Samson, Susan Leanne, Fleseriu, Maria, Bolanowski, Marek, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Manning, Patrick, Biermasz, Nienke, Giustina, Andrea, Strasburger, Christian Joseph, Melmed, Shlomo, Kennedy, Laurence
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article
MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study
Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Ur, Ehud, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Gilgun-Sherki, Yossi, Biermasz, Nienke, Strasburger, Christian Joseph, Kennedy, Laurence, Melmed, Shlomo
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article
MON-LB53 Prior Injectable Somatostatin Receptor Ligand Dose Does Not Predict Oral Octreotide Response In The Treatment Of Acromegaly: Results From The Phase 3 OPTIMAL Study
Nachtigall, Lisa B, Samson, Susan Leanne, Fleseriu, Maria, Bolanowski, Marek, Ludlam, William Henry, Patou, Gary, Haviv, Asi, Manning, Patrick, Biermasz, Nienke, Giustina, Andrea, Strasburger, Christian Joseph, Melmed, Shlomo, Kennedy, Laurence
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article
MON-314 Analysis of Adverse Events in Adult Patients with Acromegaly Receiving Oral Octreotide Capsules: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study
Labadzhyan, Artak, Samson, Susan Leanne, Nachtigall, Lisa B, Fleseriu, Maria, Ludlam, William Henry, Patou, H, Haviv, Asi, Waligorska, Agata Baldys, Biermasz, Nienke, Trainer, Peter James, Kennedy, Laurence, Melmed, Shlomo, Strasburger, Christian Joseph
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article